Skip to main content

Advertisement

SpringerLink
Log in

Pyrophosphate functionalized silver nanoparticles for colorimetric determination of deferiprone via competitive binding to Fe(III)

  • Short Communication
  • Published:
Microchimica Acta Aims and scope Submit manuscript

Abstract

The authors describe a colorimetric assay for the determination of the iron chelating drug deferiprone by using water dispersible silver nanoparticles functionalized with pyrophosphate groups (Pyro-AgNPs). The pyro-AgNPs are capable of cooperatively binding Fe3+ ions, and this results in a color change from yellow (peaking at 402 nm) to red (peaking at 520 nm) due to aggregation. However, this binding is competitively overruled, and hence aggregation is prevented in the presence of increasing concentrations of deferiprone. Consequently, the color (which is due to localized surface plasmon resonance) gradually changes from red to yellow, and this can be correlated to the concentration of the drug. The relative amounts of silver nanodispersion and pyrophosphate anions, of the pH values of the medium, and reaction times were optimized. Under the best conditions, the method exhibits a consistent optical response in the 6.0 to 100 μM deferiprone concentration range, with a 280 nM detection limit. The assay is selective over several amino acids, saccharides, and inorganic ions. The method was applied to the determination of deferiprone in pharmaceuticals and in spiked human plasma samples.

Schematic of the colorimetric deferiprone assay using pyrophosphate functionalized silver nanoparticles via competitive binding to Fe(III) ions. The probe was used to determine deferiprone in pharmaceuticals and human plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Kontoghiorghes GJ, Neocleous K, Kolnagou A (2003) Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine. Drug Saf 26:553–584

    Article  CAS  Google Scholar 

  2. Fisher SA, Brunskill SJ, Doree C, Chowdhury O, Gooding S, Roberts DJ (2013) Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database Syst Rev 8:CD004839. doi:10.1002/14651858

    Google Scholar 

  3. Pandolfo M, Hausmann L (2013) Deferiprone for the treatment of Friedreich’s ataxia. J Neurochem 126:142–146

    Article  CAS  Google Scholar 

  4. Van-Asbeck BS, Georgiou NA, Van-der-Bruggen T, Oudshoorn T, Nottet HSLM, Marx JJM (2001) Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol 20:141–147

    Article  CAS  Google Scholar 

  5. Nurchi VM, Crisponi G, Pivetta T, Donatoni M, Remelli M (2008) Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with1,2-dimethyl-3-hydroxy-4-pyridinone. J Inorg Biochem 102:684–692

    Article  CAS  Google Scholar 

  6. Abbas M, Nawaz R, Iqbal T, Alim T, Asi MR (2012) Quantitative determination of deferiprone in human plasma by reverse phase high performance liquid chromatography and its application to pharmacokinetic study. Pak J Pharm Sci 25:343–348

    CAS  Google Scholar 

  7. Limenta LMG, Jirasomprasert T, Tankanitlert J, Svasti S, Wilairat P, Chantharaksri U, Fucharoen S, Morales NP (2008) UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers. Br J Clin Pharmacol 65:908–916

    Article  CAS  Google Scholar 

  8. Klein J, Damani LA, Chung D, Epemoulu O, Olivieri N, Koren G (1991) A high performance liquid chromatographic method for the measurement of the iron chelator 1, 2-dimethyl-3-hydroxypyridin-4-one in human plasma. Ther Drug Monit 13:51–54

    Article  CAS  Google Scholar 

  9. Song TS, Hsieh TW, Peng CT, Liu CH, Chen TL, Hour MJ (2012) Development of a fast LC-MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics. Biomed Chromatogr 26:1575–1581

    Article  CAS  Google Scholar 

  10. Yadegari H, Jabbari A, Heli H, Moosavi-Movahedi AA, Majidi S (2008) Electrochemistry of deferiprone as an orally active iron chelator and HIV-1 replication inhibitor and its determination. J Braz Chem Soc 19:1017–1022

    Article  CAS  Google Scholar 

  11. Yadegari H, Jabbari A, Heli H, Moosavi-Movahedi AA, Karimian K (2008) Electro-oxidation and determination of deferiprone on a glassy carbon electrode. Chem Anal 53:5–16

    CAS  Google Scholar 

  12. Yadegari H, Jabbari A, Heli H, Moosavi-Movahedi AA, Karimian K, Khodadadi A (2008) Electrocatalytic oxidation of deferiprone and its determination on a carbon nanotube-modified glassy carbon electrode. Electrochim Acta 53:2907–2916

    Article  CAS  Google Scholar 

  13. Jamshid M, Mohammad A, Jafar S, Elanz T (2012) Development and validation of a terbium sensitized luminescence analytical method for deferiprone. Iran J Pharm Res 11:771–780

    Google Scholar 

  14. Jamshid M, Mohammad A, Jafar S, Elanz T, Rezamand A, Jouyban A (2012) Determination of deferiprone in urine and serum using a terbium- sensitized luminescence method. Luminescence 27:268–273

    Article  Google Scholar 

  15. Barot H, Shah D, Maheshwari D (2015) Development of stability indicating UV spectroscopy method for the estimation of deferiprone in pharmaceutical formulation. Am J Pharm Tech Res 5:621–632

    CAS  Google Scholar 

  16. Ahmed M, Jangade V, Shetty S, Aradhya VC, Kuppast IJ, Kumar A (2015) Development and validation of first order derivative spectrophotometric method for the estimation of deferiprone in bulk and capsule dosage form. Int J Univers Pharm Life Sci 4:169–176

    CAS  Google Scholar 

  17. Vilela D, González MC, Escarpa A (2012) Sensing colorimetric approaches based on gold and silver nanoparticles aggregation: chemical creativity behind the assay. A review. Anal Chim Acta 751:24–43

    Article  CAS  Google Scholar 

  18. Moores A, Goettmann F (2006) The plasmon band in noble metal nanoparticles: an introduction to theory and applications. New J Chem 30:1121–1132

    Article  CAS  Google Scholar 

  19. Tauran Y, Brioude A, Coleman AW, Rhimi M, Kim B (2013) Molecular recognition by gold, silver and copper nanoparticles. World J Biol Chem 4:35–63

    Google Scholar 

  20. Oliveira E, Núñez C, Santos HM, Fernández-Lodeiro J, Fernández-Lodeiro A, Capelo JL, Lodeiro C (2015) Revisiting the use of gold and silver functionalised nanoparticles as colorimetric and fluorometric chemosensors for metal ions. Sensors Actuators B Chem 212:297–328

    Article  CAS  Google Scholar 

  21. Shamsipur M, Safavi A, Mohammadpour Z, Ahmadi R (2016) Highly selective aggregation assay for visual detection of mercury ion based on competitive binding of sulfur-doped carbon nanodots to gold nanoparticles and mercury ions. Microchim Acta 183:2327–2335

    Article  CAS  Google Scholar 

  22. Luo L, Chen Y, Zhang L, Li Y, Li H, Zhang H, Tian Y (2017) SERS assay for pyrophosphate based on its competitive binding to Cu(II) ion on silver nanoparticles modified with cysteine and rhodamine 6G. Microchim Acta 184:595–601

    Article  CAS  Google Scholar 

  23. Menon SK, Modi NR, Pandya A, Lodha A (2013) Ultrasensitive and specific detection of dimethoate using a p-sulphonato-calix[4]resorcinarene functionalized silver nanoprobe in aqueous solution. RSC Adv 3:10623–10627

    Article  CAS  Google Scholar 

  24. Chavada VD, Bhatt NM, Sanyal M, Shrivastav PS (2017) Surface plasmon resonance based selective and sensitive colorimetric determination of azithromycin using unmodified silver nanoparticles in pharmaceuticals and human plasma. Spectrochim Acta A Mol Biomol Spectrosc 170:97–103

    Article  CAS  Google Scholar 

  25. Wu SP, Chen YP, Sung YM (2011) Colorimetric detection of Fe+3 using pyrophosphate functionalized gold nanoparticles. Analyst 136:1887–1891

    Article  CAS  Google Scholar 

  26. Liu ZD, Hider RC (2002) Design of iron chelators with therapeutic application. Coord Chem Rev 232:151–171

    Article  CAS  Google Scholar 

  27. Kanjanawarut R, Su XD (2009) Colorimetric detection of DNA using unmodified metallic nanoparticles and peptide nucleic acid probes. Anal Chem 81:6122–6129

    Article  CAS  Google Scholar 

  28. Furia TE (1972) Sequestrants in foods. In: Furia TE (ed) CRC handbook of food additives, 2nd edn. CRC Press, USA, pp 271–294

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad, Gujarat, 380009, India

    Vijay D. Chavada, Nejal M. Bhatt & Pranav S. Shrivastav

  2. Department of Chemistry, St. Xavier’s College, Navrangpura, Ahmedabad, Gujarat, 380009, India

    Mallika Sanyal

Authors
  1. Vijay D. Chavada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nejal M. Bhatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mallika Sanyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pranav S. Shrivastav
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pranav S. Shrivastav.

Ethics declarations

The author(s) declare that they have no competing interests.

Electronic supplementary material

ESM 1

(DOC 404 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chavada, V.D., Bhatt, N.M., Sanyal, M. et al. Pyrophosphate functionalized silver nanoparticles for colorimetric determination of deferiprone via competitive binding to Fe(III). Microchim Acta 184, 4203–4208 (2017). https://doi.org/10.1007/s00604-017-2417-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00604-017-2417-7

Keywords

Search

Navigation